Dr. Cornell completed his residency training at Children’s National Medical Center in 1999 and his pediatric critical care fellowship at the University of Michigan in 2007. His clinical expertise is in ECMO and the resuscitation and management of critically-ill children. His laboratory studies immune dysfunction which drives mortality and morbidity in critical care. Dr. Cornell is the Diagnostic Innovation Champion for the Fast Forward Medical Innovation Group at the University of Michigan and recipient of the 2017 MichBio Innovation of the Year. Dr. Cornell is a member of the Board of Directors for PreDxion Bio, Inc.